ATR improved the behaviors of CUMS-induced depression-like phenotype mice by targeting 5-HT2A, thereby increasing the levels of neurotransmitters 5-HT, DA, and NE (Pei et al., 2024). The gene discussed is HTR2A; the disease is depressive symptom measurement.